Physician profile
Joonhyun Yoon
NPI 1689661266
$2,605.64
in general payments reported to CMS, 2019-2025
20 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.37 · 2020: $58.14 · 2021: $224 · 2022: $1,678 · 2023: $106 · 2024: $161 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,447.36 | 2022 | |
| Organogenesis INC. | $399.73 | 2021-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Smith+Nephew, INC. | $132.43 | 2019-2025 | Collagenase Santyl, Grafix, Oasis |
| Sandoz INC. | $112.62 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $52.80 | 2021-2025 | Nuzyra |
| Stryker Corporation | $52.11 | 2022 | |
| Averitas Pharma INC. | $51.23 | 2023-2025 | Qutenza |
| Ets Wound Care LLC | $42.82 | 2024 | Mirragen Advanced Wound Matrix |
| Medtronic, INC. | $40.62 | 2023-2024 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $38.09 | 2024-2025 | Healix Knotless Peek, Dynacord, Na |
| Kerecis Limited | $33.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Globus Medical, INC. | $31.12 | 2025 | Senza |
| Acera Surgical, INC. | $30.26 | 2024 | Restrata Wound Matrix |
| Osteomed LLC | $29.51 | 2022 | |
| Misonix INC | $27.65 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $24.40 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.60 | 2023 | Jublia |
| Hartmann USA, INC. | $13.15 | 2021 | |
| Hikma Pharmaceuticals USA | $13.09 | 2021 | |
| Paragon 28, INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joonhyun Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.